
Joel T Adler MD MPH
Transplantation
Transplant Surgeon at Dell Medical School
Join to View Full Profile
1400 N I-35, Suite C3.400Austin, TX 78701
Phone+1 512-324-7930
Dr. Adler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Massachusetts General HospitalResidency, Surgery, 2010 - 2017
- Harvard School of Public HealthMPH, Quantitative Methods, 2013 - 2015
- University of Wisconsin School of Medicine & Public HealthClass of 2010
Certifications & Licensure
- TX State Medical License 2021 - 2025
- MA State Medical License 2013 - 2021
- WI State Medical License 2017 - 2019
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- Outcomes of Liver Transplantation in Patients With Congenital Heart Disease and Biliary Atresia. A Multicenter Analysis.Mario O'Connor, Joel T Adler, Neil M Venardos, Monica S Ponce-Rivera, Charles D Fraser
Pediatric Transplantation. 2025-08-01 - Invited Commentary.Gloria Chen, Joel T Adler
Journal of the American College of Surgeons. 2025-06-01 - Implications of Increased Medicare Advantage Enrollment for Access to Kidney Transplant Waitlisting.Joel T Adler, Arnold E Kuk, Kelsey M Drewry, Kevin H Nguyen, Adam S Wilk
Journal of the American Society of Nephrology. 2025-06-01
Journal Articles
- Hepatocellular Carcinoma in Transplantable Child-Pugh A Cirrhotics: Should Cost Affect Resection vs Transplantation?Theodoros Michelakos, Dimitrios Xourafas, David Berger, James F Markmann, Cristina R Ferrone, Motaz Qadan, Kenneth K Tanabe, Joel T Adler, Nahel Elias, Heidi Yeh, Madh..., Journal of gastrointestinal surgery
Press Mentions
- Connection, Not Exception: A Subspecialist’s Case for the AASMay 21st, 2025
Grant Support
- Evaluating the role of telehealth in patients with end stage kidney disease (ESKD)UNIVERSITY OF TEXAS AT AUSTIN2022–2027
- Evaluating the role of telehealth in patients with end stage kidney disease (ESKD)UNIVERSITY OF TEXAS AT AUSTIN2022–2027
- Evaluating the role of telehealth in patients with end stage kidney disease (ESKD)UNIVERSITY OF TEXAS AT AUSTIN2022–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: